Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
| Official URL: https://nshr-uat.sha.go.ke/fhir/ValueSet/nccp-med-clinical-category-vs | Version: 0.1.0 | ||||
| Active as of 2026-06-04 | Computable Name: MedClinicalCategoryVS | ||||
Codes classifying the clinical role of a medication in an oncology regimen.
References
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs version 📦0.1.0
Expansion performed internally based on codesystem Kenya Medication Clinical Category Code System v0.1.0 (CodeSystem)
This value set contains 10 concepts
| System | Code | Display (en) | Definition | JSON | XML |
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs | CHEMOTHERAPY | Chemotherapy | Cytotoxic agent used to kill or inhibit cancer cells. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs | IMMUNOTHERAPY | Immunotherapy | Agent that stimulates the immune system against cancer. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs | TARGETED-THERAPY | Targeted Therapy | Agent targeting specific molecular markers on cancer cells. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs | HORMONAL-THERAPY | Hormonal Therapy | Agent that blocks or modifies hormone-driven tumour growth. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs | SUPPORTIVE-CARE | Supportive Care | Medication to manage side effects or improve tolerability. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs | ANTI-EMETIC | Anti-emetic | Agent to prevent or treat nausea and vomiting. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs | GROWTH-FACTOR | Growth Factor | Colony-stimulating factor to support blood cell recovery. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs | CORTICOSTEROID | Corticosteroid | Steroid given as part of or to support the oncology regimen. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs | BISPHOSPHONATE | Bisphosphonate | Agent for prevention or treatment of bone metastasis. | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs | ANALGESIC | Analgesic | Pain management medication in the cancer care context. |